Anika Therapeutics, Inc. financial data

Symbol
ANIK on Nasdaq
Location
32 Wiggins Avenue, Bedford, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 546 % -2.17%
Quick Ratio 123 % -17.4%
Return On Equity -38.5 % -17%
Return On Assets -29.9 % -13.2%
Operating Margin -8.08 % -162%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.4M shares -2.56%
Common Stock, Shares, Outstanding 14.4M shares -2.84%
Entity Public Float 373M USD +0.73%
Common Stock, Value, Issued 144K USD -2.7%
Weighted Average Number of Shares Outstanding, Basic 14.4M shares -3.2%
Weighted Average Number of Shares Outstanding, Diluted 14.5M shares -2.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 115M USD +16.5%
Research and Development Expense 24.8M USD +41.5%
Costs and Expenses 74.8M USD +30.2%
Operating Income (Loss) -9.25M USD -173%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.47M USD -149%
Income Tax Expense (Benefit) 5.47M USD -45.1%
Net Income (Loss) Attributable to Parent -60.6M USD +18.3%
Earnings Per Share, Basic -4 USD/shares +18.4%
Earnings Per Share, Diluted -4 USD/shares +18%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.2M USD -15.4%
Marketable Securities, Current 24M USD -29.1%
Accounts Receivable, after Allowance for Credit Loss, Current 24M USD -29.1%
Inventory, Net 16.9M USD -67.1%
Assets, Current 99.3M USD -35.9%
Deferred Income Tax Assets, Net 1.25M USD -7.93%
Property, Plant and Equipment, Net 41.1M USD -13.8%
Operating Lease, Right-of-Use Asset 24.7M USD -11%
Intangible Assets, Net (Excluding Goodwill) 1.66M USD -58.2%
Goodwill 8.06M USD +9.61%
Other Assets, Noncurrent 5.55M USD -71.6%
Assets 188M USD -28.5%
Accounts Payable, Current 4.77M USD -52.3%
Employee-related Liabilities, Current 5.96M USD -29.8%
Liabilities, Current 16.1M USD -38.4%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 23.2M USD -10.1%
Other Liabilities, Noncurrent 756K USD +85.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.76M USD +25.9%
Retained Earnings (Accumulated Deficit) 62.8M USD -49.1%
Stockholders' Equity Attributable to Parent 148M USD -29.8%
Liabilities and Equity 188M USD -28.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -130K USD -3.18%
Net Cash Provided by (Used in) Financing Activities -5.44M USD -139%
Net Cash Provided by (Used in) Investing Activities 1.67M USD
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 15.4M shares +1.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.79M USD +10.6%
Deferred Tax Assets, Valuation Allowance 45.1M USD +228%
Deferred Tax Assets, Gross 59.2M USD +97%
Operating Lease, Liability 25.9M USD
Depreciation 1.3M USD +8.33%
Payments to Acquire Property, Plant, and Equipment 2.82M USD +56.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -59M USD +20.8%
Property, Plant and Equipment, Gross 90.3M USD
Operating Lease, Liability, Current 1.82M USD -20.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.47M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.78M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 18K USD -90.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.88M USD -13.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.33M USD -17.9%
Deferred Tax Assets, Operating Loss Carryforwards 650K USD -42.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.25M shares 0%
Unrecognized Tax Benefits 600K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.33M USD -11.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 800K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 14.1M USD -13.8%
Share-based Payment Arrangement, Expense 10.6M USD -17.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%